Table 4 Anatomic and Snellen visual acuity outcomes 6 months prior to IAI switch, at time of IAI switch, and 6 months after IAI switch
From: Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
# | 6 months prior to IVE switch | Time of IVE switch | 6 months after IVE switch | |||||
|---|---|---|---|---|---|---|---|---|
CRT(μ) | Change in CRT (%) | Snellen visual acuity | CRT (μ) | Snellen visual acuity | CRT (μ) | Charge in CRT (%) | Snellen visual acuity | |
1 | 299 | +9.7 | 20/40 | 398 | 20/50 | 284 | −23.1 | 20/40 |
2 | 490 | +1.0 | 20/50 | 574 | 20/200 | 267 | −44.3 | 20/70 |
3 | 496 | −10.0 | 20/30 | 463 | 20/40 | 417 | −5.7 | 20/25 |
4 | 313 | +98.1 | 20/25 | 580 | 20/200 | 454 | −34.4 | 20/200 |
5 | 460 | +6.5 | 20/70 | 459 | 20/50 | 285 | −34.5 | 20/50 |
6 | 384 | +2.2 | 20/80 | 363 | 20/40 | 341 | −5.7 | 20/40 |
7 | 383 | +24.2 | 20/100 | 469 | 20/100 | 263 | −40.0 | 20/50 |
8 | 690 | +18.6 | 20/50 | 685 | 20/200 | 423 | −13.2 | 20/200 |
9 | 353 | +13.7 | 20/70 | 496 | 20/100 | 262 | −41.9 | 20/70 |
10 | 347 | +50.5 | 20/25 | 444 | 20/40 | 283 | −36.4 | 20/25 |
11 | 498 | −9.8 | 20/50 | 428 | 20/70 | 312 | −18.6 | 20/40 |
Mean = 428 | Mean = +18.6% | Mean = 487 | Mean = 326 | Mean = −27.1% | ||||